Novartis AG to acquire Exellergy for $2 billion, expand allergy portfolio
Novartis AG will buy a US-based private biotech company, Excellergy, Inc, for $2 billion to expand its allergy portfolio.
Bharti Rana Jayshankar – Founder
She brings in more than 30 years of experience in content building, architecture, writing, editing and storytelling. Ms Jayshankar has worked in the Economic Times daily, IBT Times, Investopedia and more than a dozen content firms as a content strategist and planner.
Jay Shankar – Co-founder
He has almost three decades of experience in journalism. He has worked with national dailies such as ET, Indian Express, The Pioneer, The Hindu, Agence France Presse and Bloomberg.
Novartis AG will buy a US-based private biotech company, Excellergy, Inc, for $2 billion to expand its allergy portfolio.
Merck & Co will buy Terns Pharmaceuticals, Inc., a clinical-stage oncology company, for $6.7 billion to pocket an investigational drug to treat a.
HQ Team March 25, 2026: Novo Nordisk A/S and United Laboratories International Holdings Limited (TUL) mid-stage trials, held in China, helped in reducing.
Switzerland’s F. Hoffmann-La Roche AG upgraded its artificial intelligence infrastructure by deploying Nvidia’s technology to accelerate development of diagnostic solutions and therapeutics.
About 4.9 million children died before their fifth birthday in 2024, including 2.3 million newborns, according to a UN report.
HQ Staff Writer March 17, 2026 : Public health officials in the United Kingdom are racing to contain a fatal outbreak of meningitis B in.
High antibiotic use may have a long-term effect on a person’s gut microbiome, and certain antibiotics can cause changes in the community of.
HQ Team March 16, 2026: Academy Award-winning actress Lupita Nyong’o has ignited a vital global conversation about uterine fibroids after sharing a powerful.
Six small ribonucleic acid (RNA) molecules in the blood may be able to predict short-term survival with an 86% accuracy, a study finds.
A 13,000-year-old ice cave, located in Romania’s northwestern Apuseni mountains of Transylvania, is housing bacteria that are resistant to about 10 modern antibiotics.
We use cookies to improve your experience on our site. By using our site, you consent to cookies.
Manage your cookie preferences below:
Essential cookies enable basic functions and are necessary for the proper function of the website.
Statistics cookies collect information anonymously. This information helps us understand how visitors use our website.
Google Analytics is a powerful tool that tracks and analyzes website traffic for informed marketing decisions.
Service URL: policies.google.com